+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Chiral Chromatography Column - Global Market Trajectory & Analytics

  • ID: 5139712
  • Report
  • April 2021
  • Region: Global
  • Global Industry Analysts, Inc

FEATURED COMPANIES

  • Daicel Corporation
  • Merck & Co. Inc.
  • Phenomenex, Inc.
  • Repligen Corporation
  • Tosoh Biosciences LLC
  • W. R. Grace & Co.
Global Chiral Chromatography Column Market to Reach $117.9 Million by 2027

Amid the COVID-19 crisis, the global market for Chiral Chromatography Column estimated at US$83.1 Million in the year 2020, is projected to reach a revised size of US$117.9 Million by 2027, growing at a CAGR of 5.1% over the analysis period 2020-2027. Pharmaceutical & Biotechnology, one of the segments analyzed in the report, is projected to record a 5.3% CAGR and reach US$42.1 Million by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Food & Beverage segment is readjusted to a revised 5.7% CAGR for the next 7-year period.





The U.S. Market is Estimated at $24.5 Million, While China is Forecast to Grow at 4.9% CAGR

The Chiral Chromatography Column market in the U.S. is estimated at US$24.5 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$20.9 Million by the year 2027 trailing a CAGR of 4.9% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 4.8% and 4.3% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 4.8% CAGR.

Hospitals Segment to Record 4.8% CAGR

In the global Hospitals segment, USA, Canada, Japan, China and Europe will drive the 4.9% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$12.7 Million in the year 2020 will reach a projected size of US$17.8 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$13.2 Million by the year 2027.

Select Competitors (Total 47 Featured):
  • Agilent Technologies, Inc.
  • Daicel Corporation
  • GE Healthcare
  • Merck & Co., Inc.
  • PerkinElmer, Inc.
  • Phenomenex, Inc.
  • Regis Technologies, Inc.
  • Repligen Corporation
  • Shimadzu Corporation
  • Thermo Fisher Scientific, Inc.
  • Tosoh Biosciences LLC
  • VWR International LLC
  • W. R. Grace & Co.
  • Waters Corporation
  • ZirChrom Separations, Inc.
Frequently Asked Questions about the Global Market for Chiral Chromatography Column

What is the estimated value of the Global Market for Chiral Chromatography Column?

The Global Market for Chiral Chromatography Column was estimated to be valued at $83.1 Million in 2020.

What is the growth rate of the Global Market for Chiral Chromatography Column?

The growth rate of the Global Market for Chiral Chromatography Column is 5.1%, with an estimated value of $117.9 Million by 2027.

What is the forecasted size of the Global Market for Chiral Chromatography Column?

The Global Market for Chiral Chromatography Column is estimated to be worth $117.9 Million by 2027.

Who are the key companies in the Global Market for Chiral Chromatography Column?

Key companies in the Global Market for Chiral Chromatography Column include Agilent Technologies, Inc., Daicel Corporation, GE Healthcare, Merck & Co. Inc., PerkinElmer, Inc., Phenomenex, Inc., Regis Technologies, Inc., Repligen Corporation and Thermo Fisher Scientific, Inc..
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Daicel Corporation
  • Merck & Co. Inc.
  • Phenomenex, Inc.
  • Repligen Corporation
  • Tosoh Biosciences LLC
  • W. R. Grace & Co.

I. METHODOLOGYII. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Impact of Covid-19 and a Looming Global Recession

2. FOCUS ON SELECT PLAYERS3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
  • Table 1: World Current & Future Analysis for Chiral Chromatography Column by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2018 through 2027 and % CAGR
  • Table 2: World Historic Review for Chiral Chromatography Column by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017 and % CAGR
  • Table 3: World 15-Year Perspective for Chiral Chromatography Column by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2012, 2018 & 2027
  • Table 4: World Current & Future Analysis for Pharmaceutical & Biotechnology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2018 through 2027 and % CAGR
  • Table 5: World Historic Review for Pharmaceutical & Biotechnology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017 and % CAGR
  • Table 6: World 15-Year Perspective for Pharmaceutical & Biotechnology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2018 & 2027
  • Table 7: World Current & Future Analysis for Food & Beverage by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2018 through 2027 and % CAGR
  • Table 8: World Historic Review for Food & Beverage by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017 and % CAGR
  • Table 9: World 15-Year Perspective for Food & Beverage by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2018 & 2027
  • Table 10: World Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2018 through 2027 and % CAGR
  • Table 11: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017 and % CAGR
  • Table 12: World 15-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2018 & 2027
  • Table 13: World Current & Future Analysis for Research Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2018 through 2027 and % CAGR
  • Table 14: World Historic Review for Research Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017 and % CAGR
  • Table 15: World 15-Year Perspective for Research Laboratories by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2018 & 2027
  • Table 16: World Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2018 through 2027 and % CAGR
  • Table 17: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017 and % CAGR
  • Table 18: World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2018 & 2027

III. MARKET ANALYSIS
  • UNITED STATES
  • Table 19: USA Current & Future Analysis for Chiral Chromatography Column by End-Use - Pharmaceutical & Biotechnology, Food & Beverage, Hospitals, Research Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2018 through 2027 and % CAGR
  • Table 20: USA Historic Review for Chiral Chromatography Column by End-Use - Pharmaceutical & Biotechnology, Food & Beverage, Hospitals, Research Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017 and % CAGR
  • Table 21: USA 15-Year Perspective for Chiral Chromatography Column by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology, Food & Beverage, Hospitals, Research Laboratories and Other End-Uses for the Years 2012, 2018 & 2027
  • CANADA
  • Table 22: Canada Current & Future Analysis for Chiral Chromatography Column by End-Use - Pharmaceutical & Biotechnology, Food & Beverage, Hospitals, Research Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2018 through 2027 and % CAGR
  • Table 23: Canada Historic Review for Chiral Chromatography Column by End-Use - Pharmaceutical & Biotechnology, Food & Beverage, Hospitals, Research Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017 and % CAGR
  • Table 24: Canada 15-Year Perspective for Chiral Chromatography Column by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology, Food & Beverage, Hospitals, Research Laboratories and Other End-Uses for the Years 2012, 2018 & 2027
  • JAPAN
  • Table 25: Japan Current & Future Analysis for Chiral Chromatography Column by End-Use - Pharmaceutical & Biotechnology, Food & Beverage, Hospitals, Research Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2018 through 2027 and % CAGR
  • Table 26: Japan Historic Review for Chiral Chromatography Column by End-Use - Pharmaceutical & Biotechnology, Food & Beverage, Hospitals, Research Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017 and % CAGR
  • Table 27: Japan 15-Year Perspective for Chiral Chromatography Column by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology, Food & Beverage, Hospitals, Research Laboratories and Other End-Uses for the Years 2012, 2018 & 2027
  • CHINA
  • Table 28: China Current & Future Analysis for Chiral Chromatography Column by End-Use - Pharmaceutical & Biotechnology, Food & Beverage, Hospitals, Research Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2018 through 2027 and % CAGR
  • Table 29: China Historic Review for Chiral Chromatography Column by End-Use - Pharmaceutical & Biotechnology, Food & Beverage, Hospitals, Research Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017 and % CAGR
  • Table 30: China 15-Year Perspective for Chiral Chromatography Column by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology, Food & Beverage, Hospitals, Research Laboratories and Other End-Uses for the Years 2012, 2018 & 2027
  • EUROPE
  • Table 31: Europe Current & Future Analysis for Chiral Chromatography Column by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2018 through 2027 and % CAGR
  • Table 32: Europe Historic Review for Chiral Chromatography Column by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017 and % CAGR
  • Table 33: Europe 15-Year Perspective for Chiral Chromatography Column by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2012, 2018 & 2027
  • Table 34: Europe Current & Future Analysis for Chiral Chromatography Column by End-Use - Pharmaceutical & Biotechnology, Food & Beverage, Hospitals, Research Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2018 through 2027 and % CAGR
  • Table 35: Europe Historic Review for Chiral Chromatography Column by End-Use - Pharmaceutical & Biotechnology, Food & Beverage, Hospitals, Research Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017 and % CAGR
  • Table 36: Europe 15-Year Perspective for Chiral Chromatography Column by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology, Food & Beverage, Hospitals, Research Laboratories and Other End-Uses for the Years 2012, 2018 & 2027
  • FRANCE
  • Table 37: France Current & Future Analysis for Chiral Chromatography Column by End-Use - Pharmaceutical & Biotechnology, Food & Beverage, Hospitals, Research Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2018 through 2027 and % CAGR
  • Table 38: France Historic Review for Chiral Chromatography Column by End-Use - Pharmaceutical & Biotechnology, Food & Beverage, Hospitals, Research Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017 and % CAGR
  • Table 39: France 15-Year Perspective for Chiral Chromatography Column by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology, Food & Beverage, Hospitals, Research Laboratories and Other End-Uses for the Years 2012, 2018 & 2027
  • GERMANY
  • Table 40: Germany Current & Future Analysis for Chiral Chromatography Column by End-Use - Pharmaceutical & Biotechnology, Food & Beverage, Hospitals, Research Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2018 through 2027 and % CAGR
  • Table 41: Germany Historic Review for Chiral Chromatography Column by End-Use - Pharmaceutical & Biotechnology, Food & Beverage, Hospitals, Research Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017 and % CAGR
  • Table 42: Germany 15-Year Perspective for Chiral Chromatography Column by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology, Food & Beverage, Hospitals, Research Laboratories and Other End-Uses for the Years 2012, 2018 & 2027
  • ITALY
  • Table 43: Italy Current & Future Analysis for Chiral Chromatography Column by End-Use - Pharmaceutical & Biotechnology, Food & Beverage, Hospitals, Research Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2018 through 2027 and % CAGR
  • Table 44: Italy Historic Review for Chiral Chromatography Column by End-Use - Pharmaceutical & Biotechnology, Food & Beverage, Hospitals, Research Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017 and % CAGR
  • Table 45: Italy 15-Year Perspective for Chiral Chromatography Column by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology, Food & Beverage, Hospitals, Research Laboratories and Other End-Uses for the Years 2012, 2018 & 2027
  • UNITED KINGDOM
  • Table 46: UK Current & Future Analysis for Chiral Chromatography Column by End-Use - Pharmaceutical & Biotechnology, Food & Beverage, Hospitals, Research Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2018 through 2027 and % CAGR
  • Table 47: UK Historic Review for Chiral Chromatography Column by End-Use - Pharmaceutical & Biotechnology, Food & Beverage, Hospitals, Research Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017 and % CAGR
  • Table 48: UK 15-Year Perspective for Chiral Chromatography Column by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology, Food & Beverage, Hospitals, Research Laboratories and Other End-Uses for the Years 2012, 2018 & 2027
  • REST OF EUROPE
  • Table 49: Rest of Europe Current & Future Analysis for Chiral Chromatography Column by End-Use - Pharmaceutical & Biotechnology, Food & Beverage, Hospitals, Research Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2018 through 2027 and % CAGR
  • Table 50: Rest of Europe Historic Review for Chiral Chromatography Column by End-Use - Pharmaceutical & Biotechnology, Food & Beverage, Hospitals, Research Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017 and % CAGR
  • Table 51: Rest of Europe 15-Year Perspective for Chiral Chromatography Column by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology, Food & Beverage, Hospitals, Research Laboratories and Other End-Uses for the Years 2012, 2018 & 2027
  • ASIA-PACIFIC
  • Table 52: Asia-Pacific Current & Future Analysis for Chiral Chromatography Column by End-Use - Pharmaceutical & Biotechnology, Food & Beverage, Hospitals, Research Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2018 through 2027 and % CAGR
  • Table 53: Asia-Pacific Historic Review for Chiral Chromatography Column by End-Use - Pharmaceutical & Biotechnology, Food & Beverage, Hospitals, Research Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017 and % CAGR
  • Table 54: Asia-Pacific 15-Year Perspective for Chiral Chromatography Column by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology, Food & Beverage, Hospitals, Research Laboratories and Other End-Uses for the Years 2012, 2018 & 2027
  • REST OF WORLD
  • Table 55: Rest of World Current & Future Analysis for Chiral Chromatography Column by End-Use - Pharmaceutical & Biotechnology, Food & Beverage, Hospitals, Research Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2018 through 2027 and % CAGR
  • Table 56: Rest of World Historic Review for Chiral Chromatography Column by End-Use - Pharmaceutical & Biotechnology, Food & Beverage, Hospitals, Research Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017 and % CAGR
  • Table 57: Rest of World 15-Year Perspective for Chiral Chromatography Column by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology, Food & Beverage, Hospitals, Research Laboratories and Other End-Uses for the Years 2012, 2018 & 2027

IV. COMPETITION
  • Total Companies Profiled: 47
Note: Product cover images may vary from those shown

A selection of companies mentioned in this report includes:

  • Agilent Technologies, Inc.
  • Daicel Corporation
  • GE Healthcare
  • Merck & Co. Inc.
  • PerkinElmer, Inc.
  • Phenomenex, Inc.
  • Regis Technologies, Inc.
  • Repligen Corporation
  • Shimadzu Corporation
  • Thermo Fisher Scientific, Inc.
  • Tosoh Biosciences LLC
  • VWR International LLC
  • W. R. Grace & Co.
  • Waters Corporation
  • ZirChrom Separations, Inc.
Note: Product cover images may vary from those shown